Senior insider sale
Chief Accounting Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$291.1K
5K shares
What this filing means
LYON JOSEPH DOUGLAS plans to sell 5K shares of CORCEPT THERAPEUTICS INC valued at approximately $291.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/20/2026ACC: 0001959173-26-003811
Officer· Chief Accounting Officer
Since Jul 2020
5K
Shares to sell
$291.1K
Approx. market value
5K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months11
Purchased
cash/check
3/3/2025
216.00Stock award
Compensation
3/1/2025
325.00Purchased
cash/check
12/2/2024
215.00Stock award
Compensation
12/1/2024
295.00Purchased
cash/check
9/3/2024
372.00Stock award
Compensation
9/1/2024
232.00Purchased
cash/check
6/3/2024
1.23KStock award
Compensation
6/1/2024
923.00Stock award
Compensation
3/1/2024
681.00Purchased
cash/check
3/1/2024
507.00Purchased
cash/check
12/1/2023
2.00Total acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2025 | Purchased cash/check | 216.00 | — |
3/1/2025 | Stock award Compensation | 325.00 | — |
12/2/2024 | Purchased cash/check | 215.00 | — |
12/1/2024 | Stock award Compensation | 295.00 | — |
9/3/2024 | Purchased cash/check | 372.00 | — |
9/1/2024 | Stock award Compensation | 232.00 | — |
6/3/2024 | Purchased cash/check | 1.23K | — |
6/1/2024 | Stock award Compensation | 923.00 | — |
3/1/2024 | Stock award Compensation | 681.00 | — |
3/1/2024 | Purchased cash/check | 507.00 | — |
12/1/2023 | Purchased cash/check | 2.00 | — |
| Total | 5K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5K
Market value
$291.1K
5/20/2026
Total
Units
5K
Value
$291.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/20/2026 | 5K | $291.1K | NASDAQ | Planned |
| Total | 5K | $291.1K | ||